Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Combining a Smartphone App With Medications to Manage Heavy Drinking

for
Alcohol Use Disorder (AUD)
Location: Seattle WA, Salt Lake City UT, Phoenix AZ, Omaha NE,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06303778

Recruiting

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

for
High-Risk Prostate Cancer
Location: Seattle WA, Portland OR, West Los Angeles CA,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT05593497

Phase2, Recruiting

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

for
Metastatic Prostate Cancer
Location: Seattle WA, Portland OR, Aurora CO, Kansas City MO,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT05011383

Phase2, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Seattle WA, La Jolla CA, Rochester MN, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

for
Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea,
Location: Seattle WA, Spokane WA, Boise ID, Minneapolis MN,
Sponsor: Seattle Institute for Biomedical and Clinical Research

Sex: All

Age: 18+

Code: NCT06390345

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

for
Posttraumatic Stress Disorder (PTSD)
Location: Seattle WA, Tuscaloosa AL, Birmingham AL
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 65

Code: NCT05776056

Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Seattle WA, Vancouver WA, Salt Lake City UT,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Seattle WA, Edmonds WA, Abbotsford British Columbia,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Hypnosis and Meditation for Cancer Pain

for
Pain Related to Cancer, Cancer of Head and Neck
Location: Seattle WA
Sponsor: VA Puget Sound Health Care System

Sex: All

Age: 18+

Code: NCT03558594

Recruiting

A Crowd Sourcing Platform for Patients With Cancer

for
Cancer
Location: Seattle WA
Sponsor: All4Cure

Sex: All

Age: 18+

Code: NCT03530826

Recruiting

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Tacoma WA, Spokane WA, Fullerton CA, Milwaukee WI,
Sponsor: Panbela Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05254171

Phase2, Phase3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Puyallup WA, Lacey WA, Portland OR, Corvallis OR,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Post Falls ID, Coeur d'Alene ID, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase3, Recruiting

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

for
Spinal Muscular Atrophy (SMA)
Location: Tacoma WA, Seattle WA, Portland OR, Sacramento CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04174157

Recruiting

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Seattle WA, Sacramento CA, Los Angeles CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 2 - 17

Code: NCT05076175

Phase2, Phase3, Recruiting

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for
Sickle Cell Disease
Location: Tacoma WA, Vancouver, Calgary, Edmonton, Palo Alto CA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Tacoma WA, Seattle WA, Portland OR, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Tacoma WA, Seattle WA, Portland OR, Reno NV, Oakland CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Tacoma WA, Seattle WA, Portland OR, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Tacoma WA, Seattle WA, Portland OR, Spokane WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting